Sonia Jangra

Plitidepsin has potent preclinical efficacy against SARS-CoV-2 by targeting the host protein eEF1A

Kris M. White, Romel Rosales, Soner Yildiz et al. · Science · 2021 · 364 citations · Full text

Medicine, Infectious Diseases, Pharmacology +17

Drug-induced phospholipidosis confounds drug repurposing for SARS-CoV-2

Tia A. Tummino, Veronica V. Rezelj, Benoit Fischer et al. · Science · 2021 · 223 citations · Full text

Medicine, Infectious Diseases, Pharmacology +15

The E484K mutation in the SARS-CoV-2 spike protein reduces but does not abolish neutralizing activity of human convalescent and post-vaccination sera

Sonia Jangra, Chengjin Ye, Raveen Rathnasinghe et al. · medRxiv · 2021 · 146 citations · Full text

Life Sciences, Immunology, Infectious Diseases +14

The N501Y mutation in SARS-CoV-2 spike leads to morbidity in obese and aged mice and is neutralized by convalescent and post-vaccination human sera

Raveen Rathnasinghe, Sonia Jangra, Anastasija Čupić et al. · medRxiv · 2021 · 137 citations · Full text

Veterinary Medicine, Infectious Diseases, Pathobiology +17

TOP1 inhibition therapy protects against SARS-CoV-2-induced lethal inflammation

Jessica Ho, Bobo Wing-Yee Mok, Laura Campisi et al. · Cell · 2021 · 122 citations · Full text

Life Sciences, Immunology, Infectious Diseases +14